Abstract Background Chronic obstructive pulmonary disease (COPD) has substantial economic and human costs; it is expected to be the third leading cause of death worldwide by 2030. To minimize these costs high quality guidelines have been developed. However. guidelines alone rarely result in meaningful change. https://herbsdailyes.shop/product-category/whitening-oral-care/